ConductScience.org, home

Paper9552014

The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD.

Grossman RF. Chest, 1998. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. Papers, record 9552014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9552014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD.
PubMed
Journal
Chest
PubMed
Year
1998
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.11
iCite
Revised in PubMed
2019-05-14
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grossman RFR F

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Lung Diseases, ObstructiveMajor topic
Cause of Death
Drug Resistance, Multiple
Haemophilus Infections
Haemophilus influenzae
Humans
Respiratory Tract Infections
Treatment Failure

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
33749214[Current microbiological aspects of community respiratory infection beyond COVID-19].Rev Esp Quimioter2021https://conductscience.org/library/papers/33749214PubMed
26675667EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit.J Clin Diagn Res2015https://conductscience.org/library/papers/26675667PubMed
17535055Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study.Clin Drug Investig2003https://conductscience.org/library/papers/17535055PubMed
17523705Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany.Clin Drug Investig2004https://conductscience.org/library/papers/17523705PubMed
15892589Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.Drugs2005https://conductscience.org/library/papers/15892589PubMed
11194781The chronic obstructive pulmonary disease exacerbation.Clin Chest Med2000https://conductscience.org/library/papers/11194781PubMed
10437367[Alpha 1-protease inhibitor deficiency. Diagnosis, follow-up and therapy options].Med Klin (Munich)1999https://conductscience.org/library/papers/10437367PubMed
9708769Chronic obstructive pulmonary disease.Lancet1998https://conductscience.org/library/papers/9708769PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9552014

GET https://conductscience.org/api/papers/v1/9552014/authors